The NZ niche in translational biotech research and developing new treatments.
You are inlike to invited to the next Health Tech Network meeting which will discuss local capability in developing therapeutic products and how we might fit within the global therapeutic product development industry.
Date: 6 March
Venue: AJ Park, Level 22, Aon Centre, 1 Willis Street, Wellington
Time: 17h00 till 19h30
Programme:
17h00 - Guests arrive and networking
17h30 - Prof Juliet Gerrard PMCSA: Where can NZ researchers focus their efforts to contribute to global development of therapeutic products?
18h00 - Dr Carla Meledandri: The local capability and challenges for a researcher wanting to turn a material into a therapeutic product
18h30 - To be confirmed
19h00 to 19h30 - Networking and refreshments
Please RSVP to Kevin.Sheehy@navigator.healthcare
Speakers profiles:
Prof Juliet Gerrard: See full bio attached
Dr Carla Meledandri is a Senior Lecturer in the Department of Chemistry at the University of Otago and a Principal Investigator in the MacDiarmid Institute for Advanced Materials and Nanotechnology. She obtained her PhD in Chemistry in 2009 from Dublin City University and held a postdoctoral appointment at the same university before moving to New Zealand in late 2009. Her research is directed toward the use of colloid and surface chemistry techniques to develop new functional nanoscale materials. Carla is a co-founder of Silventum Limited, a spin-out company of the University of Otago focussed on innovative nanocomposite dental materials, and she currently serves as the company’s Chief Scientific Officer. She was the also the 2017 recipient of the New Zealand Prime Minister’s MacDiarmid Emerging Scientist Prize.
This meeting is supported by WREDA, Otago University Wellington, Victoria University of Wellington, and the Ferrier Institute. The venue is kindly supplied by AJ Park.Bio Prof Juliet Gerrard.pdf (69.2 KB)